wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34206601-93910FEC-2218-4146-ACF2-0172E3126F44
Q34206601-93910FEC-2218-4146-ACF2-0172E3126F44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34206601-93910FEC-2218-4146-ACF2-0172E3126F44
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
P2860
Q34206601-93910FEC-2218-4146-ACF2-0172E3126F44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34206601-93910FEC-2218-4146-ACF2-0172E3126F44
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52e02e4478c11b105f49c12ac9f05a6ac08ed97c
P2860
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor.